Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Medlive Technology Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$5,028.5 Mil. Medlive Technology Co's Total Assets for the quarter that ended in Dec. 2023 was HK$5,352.8 Mil.
Therefore, Medlive Technology Co's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.94.
The historical rank and industry rank for Medlive Technology Co's Equity-to-Asset or its related term are showing as below:
HKSE:02192'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.5 Med: 0.8 Max: 0.96
Current: 0.94
During the past 6 years, the highest Equity to Asset Ratio of Medlive Technology Co was 0.96. The lowest was 0.50. And the median was 0.80.
HKSE:02192's Equity-to-Asset is ranked better than 96% of 100
companies
in the Medical Distribution industry
Industry Median: 0.385
vs HKSE:02192: 0.94
Medlive Technology Co Equity-to-Asset Historical Data
The historical data trend for Medlive Technology Co's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Medlive Technology Co's Equity-to-Asset
For the Medical Distribution subindustry, Medlive Technology Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medlive Technology Co's Equity-to-Asset Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medlive Technology Co's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Medlive Technology Co's Equity-to-Asset falls into.
Medlive Technology Co Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Medlive Technology Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medlive Technology Co (HKSE:02192) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Medlive Technology Co Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Medlive Technology Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Medlive Technology Co (HKSE:02192) Business Description
Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02192 has been successfully added to your 